首页 > 最新文献

Physics and Imaging in Radiation Oncology最新文献

英文 中文
Dosimetric effect of abdominal compression in online adaptive planning for abdominal cancers treated with a 1.5 Tesla magnetic resonance-guided linear accelerator 1.5特斯拉磁共振引导直线加速器治疗腹部肿瘤在线自适应计划中腹部压缩的剂量学效应
IF 3.3 Q2 ONCOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-21 DOI: 10.1016/j.phro.2025.100899
Moghadaseh Khaleghibizaki , Angela Sobremonte , Luis Perles , Surendra Prajapati , Ergys Subashi , Yao Ding , Kristy Brock , Roya Barati , Eugene Koay , Chad Tang , Jinzhong Yang
Compression belts (CBs) are sometimes used to reduce respiratory motion during stereotactic body radiotherapy of abdominal cancers with magnetic resonance (MR)-guided online adaptive planning. This study evaluated the dosimetric effects of overriding the relative electron density (ED) value of CBs in creating synthetic computed tomography (CT) scans for MR-guided adaptive planning. We evaluated plans for 12 patients with abdominal cancer and identified that ED values between 0.2 and 0.3 achieved the best approximation of CB ED in dose calculation. Our study presented an approach to estimate appropriate ED overrides for CBs in MR-guided online adaptive planning.
压缩带(CBs)有时被用来减少呼吸运动在立体定向放射治疗腹部癌症与磁共振(MR)引导在线自适应规划。本研究评估了覆盖相对电子密度(ED)值的CBs在为磁共振引导的适应性规划创建合成计算机断层扫描(CT)时的剂量学效应。我们对12例腹部肿瘤患者的治疗方案进行了评估,发现在剂量计算中,ED值在0.2和0.3之间最接近CB ED。我们的研究提出了一种方法来估计在mr引导的在线适应性规划中CBs的适当ED覆盖。
{"title":"Dosimetric effect of abdominal compression in online adaptive planning for abdominal cancers treated with a 1.5 Tesla magnetic resonance-guided linear accelerator","authors":"Moghadaseh Khaleghibizaki ,&nbsp;Angela Sobremonte ,&nbsp;Luis Perles ,&nbsp;Surendra Prajapati ,&nbsp;Ergys Subashi ,&nbsp;Yao Ding ,&nbsp;Kristy Brock ,&nbsp;Roya Barati ,&nbsp;Eugene Koay ,&nbsp;Chad Tang ,&nbsp;Jinzhong Yang","doi":"10.1016/j.phro.2025.100899","DOIUrl":"10.1016/j.phro.2025.100899","url":null,"abstract":"<div><div>Compression belts (CBs) are sometimes used to reduce respiratory motion during stereotactic body radiotherapy of abdominal cancers with magnetic resonance (MR)-guided online adaptive planning. This study evaluated the dosimetric effects of overriding the relative electron density (ED) value of CBs in creating synthetic computed tomography (CT) scans for MR-guided adaptive planning. We evaluated plans for 12 patients with abdominal cancer and identified that ED values between 0.2 and 0.3 achieved the best approximation of CB ED in dose calculation. Our study presented an approach to estimate appropriate ED overrides for CBs in MR-guided online adaptive planning.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"37 ","pages":"Article 100899"},"PeriodicalIF":3.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145842007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementing a fully computed tomography-free online adaptive palliative radiotherapy: a one-visit workflow 实施完全免计算机断层扫描的在线自适应姑息放疗:一次访问工作流程
IF 3.3 Q2 ONCOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-20 DOI: 10.1016/j.phro.2025.100896
Ashaya T. Jaglal , Koen J. Nelissen , Angelique R.W. van Vlaenderen , Amy L. de la Fuente , Famke L. Schneiders , Peter S.N. van Rossum , Jan Wiersma , Wilko F.A.R. Verbakel , Suresh Senan , Jorrit Visser , Eva Versteijne

Background and purpose

Same-day palliative radiotherapy requires rapid workflows, but conventional computed tomography (CT)-based workflows cause delays and strain resources. Advances in cone-beam CT (CBCT) enabled accurate dose calculation and planning without a planning CT. This study evaluated the feasibility and efficiency of a fully CT-free online adaptive workflow for same-day palliative radiotherapy using high-quality CBCT.

Methods and materials

This prospective study enrolled sixteen patients between January–May 2025, of whom fifteen completed same-day treatment. Eligible patients were referred for single-fraction palliative radiotherapy (8  Gy) to non-mobile target volumes. No planning CT was acquired; instead, a reference plan was generated on a phantom with standardized beam setups and planning objectives. On the treatment day, planning and delivery were performed on the Varian Ethos 2.0 platform using HyperSight CBCT, providing more accurate Hounsfield Unit imaging for automated organs at risk segmentation and target definition. Plans were adapted online and delivered while patients were on the couch. Workflow times, plan quality, and patient characteristics were studied.

Results

All fifteen treatments were delivered successfully. All plans met clinical objectives, with planning target volume coverage exceeding required thresholds. The CT-free workflow reduced median departmental time to 73 min, including 28 min in the treatment room, compared with 335 min in a conventional CT-based workflow. In one urgent case, referral-to-treatment time was 2.5 h. Repeated CBCTs were required in 7 patients.

Conclusions

A fully CT-free workflow for palliative radiotherapy is feasible and efficient, enabling same-day treatment, reduces departmental workload, and is well-suited for urgent cases requiring rapid intervention.
当日姑息性放疗需要快速的工作流程,但传统的基于计算机断层扫描(CT)的工作流程会导致延迟和资源紧张。锥形束CT (CBCT)的进步使精确的剂量计算和计划无需计划CT。本研究评估了使用高质量CBCT进行当日姑息性放疗的完全免ct在线自适应工作流程的可行性和效率。方法和材料这项前瞻性研究在2025年1月至5月期间招募了16例患者,其中15例完成了当天的治疗。符合条件的患者接受单次姑息放疗(8 Gy)至非移动靶体积。未获得计划CT;取而代之的是,参考平面图是在具有标准化光束设置和规划目标的模型上生成的。在治疗当天,在Varian Ethos 2.0平台上使用HyperSight CBCT进行计划和交付,为自动化危险器官分割和目标定义提供更准确的Hounsfield Unit成像。病人躺在沙发上的时候,计划在网上进行调整并交付。研究了工作流程时间、计划质量和患者特征。结果15例治疗均成功。所有计划均达到临床目标,计划目标体积覆盖范围超过要求的阈值。与传统的基于ct的工作流程的335分钟相比,无ct的工作流程将平均科室时间缩短至73分钟,其中治疗室时间为28分钟。在1例紧急病例中,转诊治疗时间为2.5小时。7例患者需要重复cbct。结论完全无ct的姑息性放疗工作流程可行且高效,可实现当日治疗,减少科室工作量,适合需要快速干预的紧急病例。
{"title":"Implementing a fully computed tomography-free online adaptive palliative radiotherapy: a one-visit workflow","authors":"Ashaya T. Jaglal ,&nbsp;Koen J. Nelissen ,&nbsp;Angelique R.W. van Vlaenderen ,&nbsp;Amy L. de la Fuente ,&nbsp;Famke L. Schneiders ,&nbsp;Peter S.N. van Rossum ,&nbsp;Jan Wiersma ,&nbsp;Wilko F.A.R. Verbakel ,&nbsp;Suresh Senan ,&nbsp;Jorrit Visser ,&nbsp;Eva Versteijne","doi":"10.1016/j.phro.2025.100896","DOIUrl":"10.1016/j.phro.2025.100896","url":null,"abstract":"<div><h3>Background and purpose</h3><div>Same-day palliative radiotherapy requires rapid workflows, but conventional computed tomography (CT)-based workflows cause delays and strain resources. Advances in cone-beam CT (CBCT) enabled accurate dose calculation and planning without a planning CT. This study evaluated the feasibility and efficiency of a fully CT-free online adaptive workflow for same-day palliative radiotherapy using high-quality CBCT.</div></div><div><h3>Methods and materials</h3><div>This prospective study enrolled sixteen patients between January–May 2025, of whom fifteen completed same-day treatment. Eligible patients were referred for single-fraction palliative radiotherapy (8  Gy) to non-mobile target volumes. No planning CT was acquired; instead, a reference plan was generated on a phantom with standardized beam setups and planning objectives. On the treatment day, planning and delivery were performed on the Varian Ethos 2.0 platform using HyperSight CBCT, providing more accurate Hounsfield Unit imaging for automated organs at risk segmentation and target definition. Plans were adapted online and delivered while patients were on the couch. Workflow times, plan quality, and patient characteristics were studied.</div></div><div><h3>Results</h3><div>All fifteen treatments were delivered successfully. All plans met clinical objectives, with planning target volume coverage exceeding required thresholds. The CT-free workflow reduced median departmental time to 73 min, including 28 min in the treatment room, compared with 335 min in a conventional CT-based workflow. In one urgent case, referral-to-treatment time was 2.5 h. Repeated CBCTs were required in 7 patients.</div></div><div><h3>Conclusions</h3><div>A fully CT-free workflow for palliative radiotherapy is feasible and efficient, enabling same-day treatment, reduces departmental workload, and is well-suited for urgent cases requiring rapid intervention.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"37 ","pages":"Article 100896"},"PeriodicalIF":3.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145842009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality assurance of online adaptive radiotherapy workflows using film dosimetry in a 3D printed thorax anthropomorphic phantom 在3D打印胸腔拟人模型中使用胶片剂量法在线自适应放疗工作流程的质量保证
IF 3.3 Q2 ONCOLOGY Pub Date : 2026-01-01 Epub Date: 2026-01-22 DOI: 10.1016/j.phro.2026.100909
Daan Hoffmans , Koen Nelissen , Eva Versteijne , Wilko Verbakel

Background and purpose

Quality Assurance for online adaptive radiotherapy (oART) can be challenging. Several tests can demonstrate the dosimetric and position accuracy, but commercial phantoms are often not anatomically representative. The aim of this study was to investigate the accuracy of cone-beam computed tomography guided oART palliative and breast cancer trials by using a 3D printed thorax anthropomorphic phantom.

Materials and methods

An anthropomorphic phantom was 3D printed for this study which accommodates film through the spine, breast, heart, and lungs. Dose was measured for spine and breast treatment plans, whilst variations were simulated which can occur during treatment. Measurements were compared to calculated dose on the planning (pCT) and synthetic computed tomography (sCT) using gamma pass rate criteria of minimal 95  % (for gamma of 4  %/2 mm). Differences between the mean gamma were tested for significance.

Results

Measurements done with positional and target volume changes showed no significant difference between the gamma analyses for the pCT and sCT (p = 0.15), indicating a robust and safe workflow. For extreme variations, difference was found between gamma analyses for the pCT and sCT (p = 0.051). Pass rates were all >95  %, except for three measurements in which the sCT showed density errors up to 1000 Hounsfield Units.

Conclusions

This QA approach for oART, which used film measurements in a custom 3D-printed anthropomorphic phantom was able to validate the accuracy of the oART workflow when anatomical deviations arise and could be suitable as end-to-end test in the future.
背景和目的在线适应性放疗(oART)的质量保证具有挑战性。几个测试可以证明剂量学和位置的准确性,但商业模型往往不具有解剖学代表性。本研究的目的是通过使用3D打印的胸腔拟人化幻影来研究锥束计算机断层扫描引导的oART姑息治疗和乳腺癌试验的准确性。材料和方法本研究使用3D打印的拟人化假体,该假体可通过脊柱、乳房、心脏和肺部容纳薄膜。测量了脊柱和乳房治疗方案的剂量,同时模拟了治疗过程中可能发生的变化。测量结果与计划(pCT)和合成计算机断层扫描(sCT)上的计算剂量进行比较,使用至少95%的伽马通过率标准(伽马为4% / 2mm)。对平均值之间的差异进行显著性检验。结果位置和靶体积变化的测量结果显示pCT和sCT的伽马分析之间没有显著差异(p = 0.15),表明工作流程稳健且安全。对于极端的变异,pCT和sCT的伽马分析之间存在差异(p = 0.051)。通过率均为95%,除了三个测量中sCT显示密度误差高达1000霍斯菲尔德单位。oART的这种QA方法,在定制的3d打印拟人化幻影中使用薄膜测量,能够在解剖偏差出现时验证oART工作流程的准确性,并且可以适用于未来的端到端测试。
{"title":"Quality assurance of online adaptive radiotherapy workflows using film dosimetry in a 3D printed thorax anthropomorphic phantom","authors":"Daan Hoffmans ,&nbsp;Koen Nelissen ,&nbsp;Eva Versteijne ,&nbsp;Wilko Verbakel","doi":"10.1016/j.phro.2026.100909","DOIUrl":"10.1016/j.phro.2026.100909","url":null,"abstract":"<div><h3>Background and purpose</h3><div>Quality Assurance for online adaptive radiotherapy (oART) can be challenging. Several tests can demonstrate the dosimetric and position accuracy, but commercial phantoms are often not anatomically representative. The aim of this study was to investigate the accuracy of cone-beam computed tomography guided oART palliative and breast cancer trials by using a 3D<!--> <!-->printed thorax anthropomorphic phantom.</div></div><div><h3>Materials and methods</h3><div>An anthropomorphic phantom was 3D<!--> <!-->printed for this study which accommodates film through the spine, breast, heart, and lungs. Dose was measured for spine and breast treatment plans, whilst variations were simulated which can occur during treatment. Measurements were compared to calculated dose on the planning (pCT) and synthetic computed tomography (sCT) using gamma pass rate criteria of minimal 95<!--> <!--> % (for gamma of 4<!--> <!--> %/2<!--> <!-->mm). Differences between the mean gamma were tested for significance.</div></div><div><h3>Results</h3><div>Measurements done with positional and target volume changes showed no significant difference between the gamma analyses for the pCT and sCT (p = 0.15), indicating a robust and safe workflow. For extreme variations, difference was found between gamma analyses for the pCT and sCT (p = 0.051). Pass rates were all &gt;95<!--> <!--> %, except for three measurements in which the sCT showed density errors up to 1000 Hounsfield<!--> <!-->Units.</div></div><div><h3>Conclusions</h3><div>This QA approach for oART, which used film measurements in a custom 3D-printed anthropomorphic phantom was able to validate the accuracy of the oART workflow when anatomical deviations arise and could be suitable as end-to-end test in the future.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"37 ","pages":"Article 100909"},"PeriodicalIF":3.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep learning and dual-radiomics model incorporating brachytherapy applicator type to predict radiation-induced acute rectal injury in cervical cancer patients 深度学习和结合近距离治疗应用器类型的双放射组学模型预测宫颈癌患者放射性急性直肠损伤
IF 3.3 Q2 ONCOLOGY Pub Date : 2026-01-01 Epub Date: 2026-01-20 DOI: 10.1016/j.phro.2026.100908
Boda Ning , Zhengxian Li , Deyang Yu , Chenyu Li , Qi Liu , Yanling Bai

Background and purpose

Radiation-induced acute rectal injury (RARI) is a common early toxicity after radiotherapy for cervical cancer (CC) and remains difficult to predict before treatment, which can adversely affect life quality of patients. We aimed to develop a combined dual-radiomics and deep learning (DL) model to improve the prediction of RARI in CC patients treated with radiotherapy.

Materials and methods

This retrospective study included 200 CC patients from one hospital, randomly divided into training (n = 160), internal validation (n = 40) cohorts and external validation (n = 40) from another hospital. Patients were classified as RARI (CTCAE v5.0 grade ≥ 2) or Non-RARI (grade < 2). Radiomic and dosiomic features were extracted from CT images and dose distributions, and DL features were learned using 3D CNNs. The performance of radiomics, dosiomics, DL and hybrid features models for RARI prediction was compared using the receiver operating characteristic (ROC) curve with measurement of the area under the curve (AUC).

Results

For radiomics combining dosiomics, XGBoost achieved the best performance with AUCs of 0.786 and 0.755 in internal and external validation cohorts, respectively. For DL, Resnet_with_CBAM achieved the best performance in the input of combining CT and dose distribution with AUCs of 0.786 and 0.773 in internal and external validation cohorts, respectively. Nomogram integrating radiomics, dosiomics, DL features, and clinical factor improved the AUC to 0.810, 0.803 in internal and external validation cohorts, respectively.

Conclusion

The nomogram integrating radiomics, dosiomics, DL, and clinical factors can improve the predictive performance for RARI in CC patients followed by radiotherapy.
背景与目的放射引起的急性直肠损伤(RARI)是宫颈癌(CC)放疗后常见的早期毒性,治疗前难以预测,影响患者的生活质量。我们的目标是建立一个联合的双放射组学和深度学习(DL)模型,以提高对放射治疗的CC患者RARI的预测。材料与方法本回顾性研究纳入一家医院的200例CC患者,随机分为训练组(n = 160)、内部验证组(n = 40)和另一家医院的外部验证组(n = 40)。患者分为RARI (CTCAE v5.0分级≥2级)和非RARI(分级<; 2)。从CT图像和剂量分布中提取放射组学和剂量组学特征,并使用3D cnn学习DL特征。采用受试者工作特征(ROC)曲线和曲线下面积(AUC)测量,比较放射组学、剂量组学、DL和混合特征模型预测RARI的性能。结果对于放射组学联合剂量组学,XGBoost在内部和外部验证队列中的auc分别为0.786和0.755,表现最佳。对于DL, Resnet_with_CBAM在CT与剂量分布相结合的输入中表现最佳,在内部验证队列和外部验证队列中的auc分别为0.786和0.773。整合放射组学、剂量组学、DL特征和临床因素的Nomogram将内部验证队列和外部验证队列的AUC分别提高至0.810和0.803。结论综合放射组学、剂量组学、DL和临床因素的nomogram放射组学可提高对CC患者放疗后RARI的预测能力。
{"title":"Deep learning and dual-radiomics model incorporating brachytherapy applicator type to predict radiation-induced acute rectal injury in cervical cancer patients","authors":"Boda Ning ,&nbsp;Zhengxian Li ,&nbsp;Deyang Yu ,&nbsp;Chenyu Li ,&nbsp;Qi Liu ,&nbsp;Yanling Bai","doi":"10.1016/j.phro.2026.100908","DOIUrl":"10.1016/j.phro.2026.100908","url":null,"abstract":"<div><h3>Background and purpose</h3><div>Radiation-induced acute rectal injury (RARI) is a common early toxicity after radiotherapy for cervical cancer (CC) and remains difficult to predict before treatment, which can adversely affect life quality of patients. We aimed to develop a combined dual-radiomics and deep learning (DL) model to improve the prediction of RARI in CC patients treated with radiotherapy.</div></div><div><h3>Materials and methods</h3><div>This retrospective study included 200 CC patients from one hospital, randomly divided into training (n = 160), internal validation (n = 40) cohorts and external validation (n = 40) from another hospital. Patients were classified as RARI (CTCAE v5.0 grade ≥ 2) or Non-RARI (grade &lt; 2). Radiomic and dosiomic features were extracted from CT images and dose distributions, and DL features were learned using 3D CNNs. The performance of radiomics, dosiomics, DL and hybrid features models for RARI prediction was compared using the receiver operating characteristic (ROC) curve with measurement of the area under the curve (AUC).</div></div><div><h3>Results</h3><div>For radiomics combining dosiomics, XGBoost achieved the best performance with AUCs of 0.786 and 0.755 in internal and external validation cohorts, respectively. For DL, Resnet_with_CBAM achieved the best performance in the input of combining CT and dose distribution with AUCs of 0.786 and 0.773 in internal and external validation cohorts, respectively. Nomogram integrating radiomics, dosiomics, DL features, and clinical factor improved the AUC to 0.810, 0.803 in internal and external validation cohorts, respectively.</div></div><div><h3>Conclusion</h3><div>The nomogram integrating radiomics, dosiomics, DL, and clinical factors can improve the predictive performance for RARI in CC patients followed by radiotherapy.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"37 ","pages":"Article 100908"},"PeriodicalIF":3.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146038122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of reusing online-generated treatment plans for adaptive radiotherapy in prostate cancer 在线生成的治疗方案在前列腺癌适应性放疗中重用的可行性
IF 3.3 Q2 ONCOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-13 DOI: 10.1016/j.phro.2025.100892
Sarah A. Mason , Bethany Williams , Sophie Alexander , Alex Dunlop , Alison Tree , Emma J. Harris , Helen McNair

Background and Purpose

: Online adaptive radiotherapy (oART) is underused as generating a treatment plan at every fraction is slow and resource intensive. One method to address this involves reusing plans generated online in previous fractions with similar anatomy. However, manually assessing the suitability of each pre-existing treatment plan is prohibitively time-consuming. To gauge potential impact and motivate the development of software to enable plan recycling, we assessed a strategy whereby all pre-existing plans were considered for subsequent fractions in nine hypofractionated prostate patients treated on the magnetic resonance (MR) linear accelerator.

Methods:

The verification MR was used to estimate the delivered dose after adaptation to establish a Current Clinical Practice Benchmark. Each structure from the daily MR was propagated backwards onto the reference and daily MRs from previous fractions to calculate the dose to each structure that would have been received had the corresponding plan been delivered. The resulting dose statistics were assessed against: (A) standard target and organ-at-risk objectives, (B) the Current Clinical Practice Benchmark, and (C) circumstances where a pre-existing plan would have matched or outperformed the online plan.

Results:

The median [interquartile range] percentage of fractions with at least one acceptable pre-existing plan was 25% [20%], 40% [35%], and 60% [20%] for criteria A, B, and C respectively. Reusing the reference plan was only acceptable in 0%–20% of fractions.

Conclusion:

Reusing pre-existing plans is feasible and could accelerate oART and reduce hospital resources in approximately 40% of fractions whilst achieving the same dose-volume metrics as current oART workflows.
背景与目的:在线自适应放疗(oART)未得到充分利用,因为在每个部分生成治疗计划都是缓慢且资源密集的。解决这个问题的一种方法是重用在先前具有类似解剖结构的分数中在线生成的计划。然而,手动评估每个预先存在的治疗方案的适用性是非常耗时的。为了评估潜在的影响和激励软件的开发,使计划回收,我们评估了一种策略,即所有预先存在的计划都被考虑用于9名接受磁共振(MR)线性加速器治疗的低分数前列腺患者的后续分数。方法:采用核磁共振验证法估算适应后给药剂量,建立现行临床实践基准。每日MR中的每个结构被反向传播到参考和以前的每日MR中,以计算如果提供相应的计划,每个结构将会收到的剂量。得出的剂量统计数据是根据以下条件进行评估的:(A)标准目标和器官危险目标,(B)当前临床实践基准,以及(C)预先存在的计划与在线计划相匹配或优于在线计划的情况。结果:对于标准A、B和C,至少有一个可接受的既存计划的分数的中位数[四分位数范围]百分比分别为25%[20%]、40%[35%]和60%[20%]。参考计划的重用仅在0%-20%的分数中是可接受的。结论:重复使用已有的计划是可行的,可以加速oART并减少大约40%的医院资源,同时实现与当前oART工作流程相同的剂量-体积指标。
{"title":"Feasibility of reusing online-generated treatment plans for adaptive radiotherapy in prostate cancer","authors":"Sarah A. Mason ,&nbsp;Bethany Williams ,&nbsp;Sophie Alexander ,&nbsp;Alex Dunlop ,&nbsp;Alison Tree ,&nbsp;Emma J. Harris ,&nbsp;Helen McNair","doi":"10.1016/j.phro.2025.100892","DOIUrl":"10.1016/j.phro.2025.100892","url":null,"abstract":"<div><h3>Background and Purpose</h3><div>: Online adaptive radiotherapy (oART) is underused as generating a treatment plan at every fraction is slow and resource intensive. One method to address this involves reusing plans generated online in previous fractions with similar anatomy. However, manually assessing the suitability of each pre-existing treatment plan is prohibitively time-consuming. To gauge potential impact and motivate the development of software to enable plan recycling, we assessed a strategy whereby <em>all</em> pre-existing plans were considered for subsequent fractions in nine hypofractionated prostate patients treated on the magnetic resonance (MR) linear accelerator.</div></div><div><h3>Methods:</h3><div>The verification MR was used to estimate the delivered dose after adaptation to establish a Current Clinical Practice Benchmark. Each structure from the daily MR was propagated backwards onto the reference and daily MRs from previous fractions to calculate the dose to each structure that would have been received had the corresponding plan been delivered. The resulting dose statistics were assessed against: (A) standard target and organ-at-risk objectives, (B) the Current Clinical Practice Benchmark, and (C) circumstances where a pre-existing plan would have matched or outperformed the online plan.</div></div><div><h3>Results:</h3><div>The median [interquartile range] percentage of fractions with at least one acceptable pre-existing plan was 25% [20%], 40% [35%], and 60% [20%] for criteria A, B, and C respectively. Reusing the reference plan was only acceptable in 0%–20% of fractions.</div></div><div><h3>Conclusion:</h3><div>Reusing pre-existing plans is feasible and could accelerate oART and reduce hospital resources in approximately 40% of fractions whilst achieving the same dose-volume metrics as current oART workflows.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"37 ","pages":"Article 100892"},"PeriodicalIF":3.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145799270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of radiomics-based image filtering to improve deformable image registration accuracy in thoracic images 基于放射学的图像滤波在胸部图像中提高变形图像配准精度的应用
IF 3.3 Q2 ONCOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-16 DOI: 10.1016/j.phro.2025.100894
Yoshiro Ieko , Noriyuki Kadoya , Hisanori Ariga

Background and purpose

Deformable image registration (DIR) is an important technique in radiation therapy. To improve DIR accuracy, we applied radiomics-based image filtering as a preprocessing step before DIR.

Materials and methods

Thoracic four-dimensional computed tomography (CT) images of 10 patients with lung or esophageal cancer were examined. Peak-inhale and peak-exhale images were used for DIR. Before DIR, these images were converted into 90-voxel-based radiomics-based filtered images using extracted local radiomics features, respectively. On each filtered image, DIR between the peak-inhale and peak-exhale filtered images was performed. After DIR, the peak-inhale CT images were deformed to peak-exhale CT images using the displacement vector fields obtained from the DIR. The registration errors obtained from each radiomics-based DIR were calculated using landmark pairs and compared with conventional CT-based DIR using the same DIR parameters.

Results

In radiomics-based DIR, the lowest registration errors (95th percentile) for intensity and texture features were 0.96 mm (right-left), 1.35–1.38 mm (anterior-posterior), 2.04–2.13 mm (superior-inferior), and 2.49–2.57 mm (three-dimensional). For CT-based DIR, the corresponding registration errors were 1.31 mm, 1.72 mm, 3.45 mm, and 3.98 mm.

Conclusions

By applying radiomics-based image filtering before DIR as a preprocessing, the registration error was lower than that of conventional CT-based DIR, suggesting that using radiomics may improve the accuracy of DIR.
背景与目的形变图像配准是放射治疗中的一项重要技术。为了提高DIR的精度,我们在DIR前使用基于放射学的图像滤波作为预处理步骤。材料与方法对10例肺癌或食管癌患者的胸部四维计算机断层扫描(CT)图像进行分析。吸气峰和呼气峰图像用于DIR。在DIR之前,这些图像分别使用提取的局部放射组学特征转换为基于90体素的基于放射组学的滤波图像。在每个过滤图像上,在峰值吸气和峰值呼气过滤图像之间执行DIR。在DIR后,利用从DIR中获得的位移向量场将吸气峰CT图像变形为呼气峰CT图像。使用地标对计算每个基于放射组学的DIR得到的配准误差,并与使用相同DIR参数的基于ct的常规DIR进行比较。结果在基于放射组学的DIR中,强度和纹理特征的最小配准误差(95百分位数)分别为0.96 mm(左右)、1.35 ~ 1.38 mm(前后)、2.04 ~ 2.13 mm(上下)和2.49 ~ 2.57 mm(三维)。对于基于ct的DIR,相应的配准误差分别为1.31 mm、1.72 mm、3.45 mm和3.98 mm。结论通过在DIR前进行基于放射组学的图像滤波预处理,配准误差低于传统的基于ct的DIR,表明使用放射组学可以提高DIR的准确性。
{"title":"Application of radiomics-based image filtering to improve deformable image registration accuracy in thoracic images","authors":"Yoshiro Ieko ,&nbsp;Noriyuki Kadoya ,&nbsp;Hisanori Ariga","doi":"10.1016/j.phro.2025.100894","DOIUrl":"10.1016/j.phro.2025.100894","url":null,"abstract":"<div><h3>Background and purpose</h3><div>Deformable image registration (DIR) is an important technique in radiation therapy. To improve DIR accuracy, we applied radiomics-based image filtering as a preprocessing step before DIR.</div></div><div><h3>Materials and methods</h3><div>Thoracic four-dimensional computed tomography (CT) images of 10 patients with lung or esophageal cancer were examined. Peak-inhale and peak-exhale images were used for DIR. Before DIR, these images were converted into 90-voxel-based radiomics-based filtered images using extracted local radiomics features, respectively. On each filtered image, DIR between the peak-inhale and peak-exhale filtered images was performed. After DIR, the peak-inhale CT images were deformed to peak-exhale CT images using the displacement vector fields obtained from the DIR. The registration errors obtained from each radiomics-based DIR were calculated using landmark pairs and compared with conventional CT-based DIR using the same DIR parameters.</div></div><div><h3>Results</h3><div>In radiomics-based DIR, the lowest registration errors (95th percentile) for intensity and texture features were 0.96 mm (right-left), 1.35–1.38 mm (anterior-posterior), 2.04–2.13 mm (superior-inferior), and 2.49–2.57 mm (three-dimensional). For CT-based DIR, the corresponding registration errors were 1.31 mm, 1.72 mm, 3.45 mm, and 3.98 mm.</div></div><div><h3>Conclusions</h3><div>By applying radiomics-based image filtering before DIR as a preprocessing, the registration error was lower than that of conventional CT-based DIR, suggesting that using radiomics may improve the accuracy of DIR.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"37 ","pages":"Article 100894"},"PeriodicalIF":3.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145799272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and characterization of phantoms to investigate the Flash effect with Drosophila melanogaster at an ultra-high dose rate radiotherapy linac 研究超高剂量率直线放射治疗下黑腹果蝇的闪效应
IF 3.3 Q2 ONCOLOGY Pub Date : 2025-10-01 Epub Date: 2025-09-15 DOI: 10.1016/j.phro.2025.100835
Riccardo Dal Bello , Marvin Kreuzer , Irene Vetrugno , Jamie C. Little , Rafael Kranzer , Stefan Schischke , Lily Bossin , Eduardo Gardenali Yukihara , Matthias Guckenberger , Martin Pruschy , Stephanie Tanadini-Lang

Background and purpose

Ultra-high dose rate (UHDR) radiotherapy may widen the therapeutic window thanks to the Flash effect. Experimental linear accelerators have been converted to UHDR to collect pre-clinical evidence. Increasing the accessibility, throughput and investigating additional biological endpoints is key for deciphering the mechanism of the Flash effect. The aim of this study was to develop and characterise an experimental platform for UHDR experiments with Drosophila melanogaster, i.e. the fruit fly.

Materials and methods

A clinical linear accelerator was modified to deliver 16 MeV electron beams in UHDR and conventional (CONV) mode. Two phantoms were developed to irradiate Drosophila melanogaster. The characterization was based both on active (ultra-thin ion chamber prototype, scintillator) and passive detectors (radiochromic films, OSLD). Moreover, the UHDR capabilities for megavoltage photon were investigated with an additional dedicated phantom.

Results

The electron UHDR irradiations provided average dose rates in the range of 200–––7500 Gy/s. The beam spatial uniformity within a single vial was better than ± 5 %. The dose delivered to Drosophila melanogaster in different configurations and beam modalities was confirmed to the ± 5 % level. The average dose rate achieved with photon megavoltage UHDR radiation reached beyond 40 Gy/s.

Conclusions

This high-throughput experimental platform on a converted clinical linear accelerator could be used to compare CONV to UHDR for up to 500 animals per week for biological endpoints at up to 1000 Gy. The production of photon megavoltage UHDR radiation was also demonstrated for the first time at a converted clinical linac.
背景与目的超高剂量率放射治疗因其闪光效应而拓宽了治疗窗口。实验性线性加速器已转换为超高dr,以收集临床前证据。增加可及性、吞吐量和研究额外的生物端点是破解Flash效应机制的关键。本研究的目的是开发和表征一个用果蝇(即果蝇)进行UHDR实验的实验平台。材料和方法对一种临床直线加速器进行了改进,使其能够在UHDR和常规(CONV)模式下输出16 MeV的电子束。两个幻影被开发用来照射黑腹果蝇。表征是基于主动(超薄离子室原型,闪烁体)和被动探测器(放射性变色薄膜,OSLD)。此外,利用额外的专用模体研究了超高压光子的超高dr能力。结果电子UHDR辐照的平均剂量率为200 ~ 7500 Gy/s。单瓶内光束空间均匀性优于±5%。以不同形态和光束方式给黑腹果蝇的剂量确认为±5%水平。光子特高压辐射的平均剂量率达到40 Gy/s以上。结论:该高通量实验平台在经过改装的临床线性加速器上,可用于比较CONV和UHDR,每周最多500只动物,生物终点高达1000 Gy。在一个改装的临床直线加速器上,也首次证明了光子巨压UHDR辐射的产生。
{"title":"Development and characterization of phantoms to investigate the Flash effect with Drosophila melanogaster at an ultra-high dose rate radiotherapy linac","authors":"Riccardo Dal Bello ,&nbsp;Marvin Kreuzer ,&nbsp;Irene Vetrugno ,&nbsp;Jamie C. Little ,&nbsp;Rafael Kranzer ,&nbsp;Stefan Schischke ,&nbsp;Lily Bossin ,&nbsp;Eduardo Gardenali Yukihara ,&nbsp;Matthias Guckenberger ,&nbsp;Martin Pruschy ,&nbsp;Stephanie Tanadini-Lang","doi":"10.1016/j.phro.2025.100835","DOIUrl":"10.1016/j.phro.2025.100835","url":null,"abstract":"<div><h3>Background and purpose</h3><div>Ultra-high dose rate (UHDR) radiotherapy may widen the therapeutic window thanks to the Flash effect. Experimental linear accelerators have been converted to UHDR to collect pre-clinical evidence. Increasing the accessibility, throughput and investigating additional biological endpoints is key for deciphering the mechanism of the Flash effect. The aim of this study was to develop and characterise an experimental platform for UHDR experiments with <em>Drosophila melanogaster</em>, i.e. the fruit fly.</div></div><div><h3>Materials and methods</h3><div>A clinical linear accelerator was modified to deliver 16 MeV electron beams in UHDR and conventional (CONV) mode. Two phantoms were developed to irradiate <em>Drosophila melanogaster</em>. The characterization was based both on active (ultra-thin ion chamber prototype, scintillator) and passive detectors (radiochromic films, OSLD). Moreover, the UHDR capabilities for megavoltage photon were investigated with an additional dedicated phantom.</div></div><div><h3>Results</h3><div>The electron UHDR irradiations provided average dose rates in the range of 200–––7500 Gy/s. The beam spatial uniformity within a single vial was better than ± 5 %. The dose delivered to <em>Drosophila</em> melanogaster in different configurations and beam modalities was confirmed to the ± 5 % level. The average dose rate achieved with photon megavoltage UHDR radiation reached beyond 40 Gy/s.</div></div><div><h3>Conclusions</h3><div>This high-throughput experimental platform on a converted clinical linear accelerator could be used to compare CONV to UHDR for up to 500 animals per week for biological endpoints at up to 1000 Gy. The production of photon megavoltage UHDR radiation was also demonstrated for the first time at a converted clinical linac.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"36 ","pages":"Article 100835"},"PeriodicalIF":3.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishing prospective performance monitoring for real-world implementation of deep learning-based auto-segmentation in prostate cancer radiotherapy 为前列腺癌放疗中基于深度学习的自动分割的实际实施建立前瞻性性能监测
IF 3.3 Q2 ONCOLOGY Pub Date : 2025-10-01 Epub Date: 2025-12-04 DOI: 10.1016/j.phro.2025.100886
Libing Zhu , Yi Rong , Nathan Y. Yu , Jason M. Holmes , Carlos E. Vargas , Sarah E. James , Lu Shang , Jean-Claude M. Rwigema , Quan Chen

Background and purpose

Deep-learning auto-segmentation (DLAS) performance in radiotherapy may change over time due to data shift/drift or practice changes, yet guidance for quality assurance is lacking. This study developed a practical framework for prospective performance monitoring using retrospective data.

Methods

A total of 464 prostate cases over 20 months were retrospectively collected. Two commercial DLAS models were clinically used: model A (2D U-Net, January 2022–January 2023) and model B (3D U-Net, February–August 2023). The agreement between DLAS and clinical contours was assessed using Dice Similarity Coefficient (DSC), 95th percentile Hausdorff Distance (HD95), and Surface DSC with a 2 mm tolerance (SDSC). Statistical process control charts were created to monitor performance drift and model switching. The first 150 cases were used to define organ-specific control limits with two and three standard deviations of monthly mean values, σx¯.

Results

2σx¯ and 3σx¯-based control limits were established for the monthly average charts, ranging from DSC 0.82–0.97, HD95 1.4–10.5 mm, and SDSC 0.45–0.91 across organs. Model A showed stable performance, with 9–13 months per organ remaining within the 3σx¯ thresholds. In contrast, model B demonstrated a marked performance shift (p < 0.001), with all five organs exceeding both thresholds across all 7 months. The 2σx¯ thresholds were more sensitive in detecting mild deviations for model A, while both limits effectively identified the substantial drift of model B.

Conclusion

The monitoring system effectively detected out-of-distribution outliers and clinical practice changes, providing a reliable framework for early detection of monthly performance degradation.
背景和目的放疗中的深度学习自动分割(DLAS)性能可能会随着时间的推移而变化,因为数据移位/漂移或实践变化,但缺乏质量保证的指导。本研究开发了一个使用回顾性数据进行前瞻性绩效监测的实用框架。方法回顾性收集近20个月464例前列腺癌患者的资料。临床使用两种商用DLAS模型:A模型(2D U-Net, 2022年1月- 2023年1月)和B模型(3D U-Net, 2023年2月- 8月)。采用Dice Similarity Coefficient (DSC)、第95百分位Hausdorff Distance (HD95)和Surface DSC与2mm容差(SDSC)来评估DLAS与临床轮廓的一致性。创建了统计过程控制图来监视性能漂移和模型切换。用前150例的月平均值σx¯的2和3个标准差来定义器官特异性控制极限。结果建立了2σx¯和3σx¯的月平均图控制限,各器官间DSC为0.82 ~ 0.97,HD95为1.4 ~ 10.5 mm, SDSC为0.45 ~ 0.91。模型A表现出稳定的性能,每个器官9-13个月保持在3σx¯阈值内。相比之下,模型B表现出明显的性能变化(p < 0.001),所有五个器官在所有7个月内都超过了两个阈值。2σx¯阈值在检测模型A的轻微偏差时更为敏感,而两个阈值都能有效识别模型b的重大偏差。结论监测系统能有效检测出分布外异常值和临床实践变化,为早期检测月度性能下降提供了可靠的框架。
{"title":"Establishing prospective performance monitoring for real-world implementation of deep learning-based auto-segmentation in prostate cancer radiotherapy","authors":"Libing Zhu ,&nbsp;Yi Rong ,&nbsp;Nathan Y. Yu ,&nbsp;Jason M. Holmes ,&nbsp;Carlos E. Vargas ,&nbsp;Sarah E. James ,&nbsp;Lu Shang ,&nbsp;Jean-Claude M. Rwigema ,&nbsp;Quan Chen","doi":"10.1016/j.phro.2025.100886","DOIUrl":"10.1016/j.phro.2025.100886","url":null,"abstract":"<div><h3>Background and purpose</h3><div>Deep-learning auto-segmentation (DLAS) performance in radiotherapy may change over time due to data shift/drift or practice changes, yet guidance for quality assurance is lacking. This study developed a practical framework for prospective performance monitoring using retrospective data.</div></div><div><h3>Methods</h3><div>A total of 464 prostate cases over 20 months were retrospectively collected. Two commercial DLAS models were clinically used: model A (2D U-Net, January 2022–January 2023) and model B (3D U-Net, February–August 2023). The agreement between DLAS and clinical contours was assessed using Dice Similarity Coefficient (DSC), 95th percentile Hausdorff Distance (HD95), and Surface DSC with a 2 mm tolerance (SDSC). Statistical process control charts were created to monitor performance drift and model switching. The first 150 cases were used to define organ-specific control limits with two and three standard deviations of monthly mean values, <span><math><mrow><msub><mi>σ</mi><mover><mrow><mi>x</mi></mrow><mrow><mo>¯</mo></mrow></mover></msub></mrow></math></span>.</div></div><div><h3>Results</h3><div>2<span><math><mrow><msub><mi>σ</mi><mover><mrow><mi>x</mi></mrow><mrow><mo>¯</mo></mrow></mover></msub></mrow></math></span> and 3<span><math><mrow><msub><mi>σ</mi><mover><mrow><mi>x</mi></mrow><mrow><mo>¯</mo></mrow></mover></msub></mrow></math></span>-based control limits were established for the monthly average charts, ranging from DSC 0.82–0.97, HD95 1.4–10.5 mm, and SDSC 0.45–0.91 across organs. Model A showed stable performance, with 9–13 months per organ remaining within the 3<span><math><mrow><msub><mi>σ</mi><mover><mrow><mi>x</mi></mrow><mrow><mo>¯</mo></mrow></mover></msub></mrow></math></span> thresholds. In contrast, model B demonstrated a marked performance shift (p &lt; 0.001), with all five organs exceeding both thresholds across all 7 months. The 2<span><math><mrow><msub><mi>σ</mi><mover><mrow><mi>x</mi></mrow><mrow><mo>¯</mo></mrow></mover></msub></mrow></math></span> thresholds were more sensitive in detecting mild deviations for model A, while both limits effectively identified the substantial drift of model B.</div></div><div><h3>Conclusion</h3><div>The monitoring system effectively detected out-of-distribution outliers and clinical practice changes, providing a reliable framework for early detection of monthly performance degradation.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"36 ","pages":"Article 100886"},"PeriodicalIF":3.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Apparent diffusion coefficient increases during short course radiotherapy in rectal tumours: Results from a multicentre longitudinal trial 在直肠肿瘤的短期放疗中,表观扩散系数增加:来自一项多中心纵向试验的结果
IF 3.3 Q2 ONCOLOGY Pub Date : 2025-10-01 Epub Date: 2025-12-02 DOI: 10.1016/j.phro.2025.100880
Anne L.H. Bisgaard , Chavelli M. Kensen , Marielle E.P. Philippens , Martijn P.W. Intven , Gert J. Meijer , Alice M. Couwenberg , Doenja M.J. Lambregts , Uulke A. van der Heide , Erik van der Bijl , Pètra M. Braam , Faisal Mahmood , Petra J. van Houdt

Background and purpose

The apparent diffusion coefficient (ADC) derived from diffusion-weighted imaging (DWI), a form of magnetic resonance imaging (MRI), has shown promise for predicting response to long course neoadjuvant chemoradiotherapy in rectal cancer. This study investigated whether ADC changes are detectable during short course radiotherapy in patients with rectal cancer.

Materials and methods

Across 3 centres, this study included 138 patients with primary tumours, who received neoadjuvant short course radiotherapy (5 fractions of 5 Gy) on a 1.5 T MRI linear accelerator (MRI-linac), without any prior oncological treatments. DWI was acquired at each fraction prior to beam-on. ADC maps were calculated centrally using a mono-exponential model using b-values between 150–800 s/mm2. Median scaling of ADC voxel values was performed between two identified groups of DWI sequences. Tumours were semi-automatically delineated on DWI, and median ADCs were extracted per fraction. ADC time-trends over the course of radiotherapy were extracted using linear fitting, with 95% confidence intervals (CI) estimated using bootstrapping.

Results

A scaling factor of 0.93 was used to account for ADC variation between the DWI sequence groups. The median (range) slope of the ADC time-trends was 0.05 (−0.18, 0.42) 10−3mm2/s/fraction. In 77 patients (56%), the 95% CI of the slope did not include zero.

Conclusions

ADC changes during short course radiotherapy were detectable in 56% of the patients. Furthermore, the limited ADC variation across DWI sequences supports feasibility of multicentre investigations of MRI-linac based DWI. These findings encourage future research linking ADC to clinical outcomes in rectal cancer for potential treatment personalization.
背景与目的磁共振成像(MRI)的一种形式——弥散加权成像(DWI)得出的表观扩散系数(ADC)有望预测直肠癌患者对长期新辅助放化疗的反应。本研究探讨了在直肠癌患者的短期放疗中是否可以检测到ADC的变化。材料和方法本研究纳入了3个中心的138例原发肿瘤患者,这些患者在1.5 T MRI直线加速器(MRI-linac)上接受了新辅助短期放疗(5 Gy的5个部分),之前没有任何肿瘤治疗。在光束照射前,在每个分数处获取DWI。ADC图使用单指数模型集中计算,b值在150-800 s/mm2之间。在确定的两组DWI序列之间进行ADC体素值的中位数缩放。在DWI上半自动划定肿瘤,并提取每个分数的中位adc。放疗过程中的ADC时间趋势采用线性拟合提取,95%置信区间(CI)采用自举法估计。结果DWI序列组间ADC差异的比例因子为0.93。ADC时间趋势的中位(范围)斜率为0.05 (- 0.18,0.42)10 - 3mm2/s/fraction。在77例(56%)患者中,斜率的95% CI不为零。结论56%的患者在短期放疗中可检测到sadc的改变。此外,DWI序列之间有限的ADC变化支持了基于MRI-linac的DWI多中心研究的可行性。这些发现鼓励未来的研究将ADC与直肠癌的临床结果联系起来,以实现潜在的个性化治疗。
{"title":"Apparent diffusion coefficient increases during short course radiotherapy in rectal tumours: Results from a multicentre longitudinal trial","authors":"Anne L.H. Bisgaard ,&nbsp;Chavelli M. Kensen ,&nbsp;Marielle E.P. Philippens ,&nbsp;Martijn P.W. Intven ,&nbsp;Gert J. Meijer ,&nbsp;Alice M. Couwenberg ,&nbsp;Doenja M.J. Lambregts ,&nbsp;Uulke A. van der Heide ,&nbsp;Erik van der Bijl ,&nbsp;Pètra M. Braam ,&nbsp;Faisal Mahmood ,&nbsp;Petra J. van Houdt","doi":"10.1016/j.phro.2025.100880","DOIUrl":"10.1016/j.phro.2025.100880","url":null,"abstract":"<div><h3>Background and purpose</h3><div>The apparent diffusion coefficient (ADC) derived from diffusion-weighted imaging (DWI), a form of magnetic resonance imaging (MRI), has shown promise for predicting response to long course neoadjuvant chemoradiotherapy in rectal cancer. This study investigated whether ADC changes are detectable during short course radiotherapy in patients with rectal cancer.</div></div><div><h3>Materials and methods</h3><div>Across 3 centres, this study included 138 patients with primary tumours, who received neoadjuvant short course radiotherapy (5 fractions of 5 Gy) on a 1.5 T MRI linear accelerator (MRI-linac), without any prior oncological treatments. DWI was acquired at each fraction prior to beam-on. ADC maps were calculated centrally using a mono-exponential model using b-values between 150–800 s/mm<sup>2</sup>. Median scaling of ADC voxel values was performed between two identified groups of DWI sequences. Tumours were semi-automatically delineated on DWI, and median ADCs were extracted per fraction. ADC time-trends over the course of radiotherapy were extracted using linear fitting, with 95% confidence intervals (CI) estimated using bootstrapping.</div></div><div><h3>Results</h3><div>A scaling factor of 0.93 was used to account for ADC variation between the DWI sequence groups. The median (range) slope of the ADC time-trends was 0.05 (−0.18, 0.42) 10<sup>−3</sup>mm<sup>2</sup>/s/fraction. In 77 patients (56%), the 95% CI of the slope did not include zero.</div></div><div><h3>Conclusions</h3><div>ADC changes during short course radiotherapy were detectable in 56% of the patients. Furthermore, the limited ADC variation across DWI sequences supports feasibility of multicentre investigations of MRI-linac based DWI. These findings encourage future research linking ADC to clinical outcomes in rectal cancer for potential treatment personalization.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"36 ","pages":"Article 100880"},"PeriodicalIF":3.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145681028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A proof of concept for improving comparability of dosimetry audits through centralised planning 通过集中规划提高剂量学审计可比性的概念证明
IF 3.3 Q2 ONCOLOGY Pub Date : 2025-10-01 Epub Date: 2025-11-29 DOI: 10.1016/j.phro.2025.100879
José Antonio Baeza-Ortega , Lauren May , Mohammad Hussein , Sarah Porter , Alisha Moore , Peter B. Greer , Catharine H. Clark , Joerg Lehmann

Background and purpose

The role of dosimetry audits is well established in the development and verification of radiotherapy safety. Differences in planning and beam modelling make inter-centre comparisons challenging, which can be addressed through distribution of centrally created plans. This study developed a centralised planning approach applicable to multiple audit methodologies, using an example of remote patient specific quality assurance assessment, increasing the interpretability of results and facilitating automation and scalability.

Material and methods

Starting with an established plan which met all clinical goals, a commercial dose mimicking algorithm was used to replicate this plan to be suitable for multiple treatment machines. Beam and machine limitation data were collected from participating centres to develop universally acceptable beam models. The influence of variation in beam modelling parameters among centres was assessed by creating additional models using the 2.5th, 25th, 75th and 97.5th percentiles of previously reported data. Multi-leaf collimator angle and leaf position, gantry angle and output deviations were then introduced into copies of these plans.

Results

Introduced delivery errors caused consistent change in dose metrics across machine models (excluding outliers) with a median (range) standard deviation of 1.0 % (from 0.1 % to 1.7 %) demonstrating similar robustness. Beam model variation did not change whether simulated delivery errors were clinically impactful or not for 95 % of tested plans.

Conclusion

This study lays the foundation for future standardised methodology for dosimetry audits by providing a centralised planning approach that allows a more consistent assessment of centres.
背景和目的剂量学审核在放射治疗安全性的制定和验证中的作用已得到充分确立。规划和光束建模的差异使得中心间比较具有挑战性,这可以通过中央创建的计划的分布来解决。本研究开发了一种适用于多种审计方法的集中规划方法,以远程患者特定质量保证评估为例,提高了结果的可解释性,促进了自动化和可扩展性。材料和方法从满足所有临床目标的既定计划开始,使用商业剂量模拟算法来复制该计划,以适用于多个治疗机器。从参与中心收集光束和机器限制数据,以开发普遍接受的光束模型。通过使用先前报告数据的第2.5、第25、第75和第975百分位创建额外的模型,评估了中心之间光束建模参数变化的影响。然后将多叶准直器角度和叶片位置、龙门角度和输出偏差引入到这些平面图的副本中。结果引入的给药错误导致不同机器模型(不包括异常值)剂量计量的一致变化,中位(范围)标准差为1.0%(从0.1%到1.7%),显示出类似的稳健性。对于95%的测试计划,光束模型的变化并没有改变模拟分娩错误是否对临床有影响。本研究通过提供一种允许对中心进行更一致评估的集中规划方法,为未来剂量学审计的标准化方法奠定了基础。
{"title":"A proof of concept for improving comparability of dosimetry audits through centralised planning","authors":"José Antonio Baeza-Ortega ,&nbsp;Lauren May ,&nbsp;Mohammad Hussein ,&nbsp;Sarah Porter ,&nbsp;Alisha Moore ,&nbsp;Peter B. Greer ,&nbsp;Catharine H. Clark ,&nbsp;Joerg Lehmann","doi":"10.1016/j.phro.2025.100879","DOIUrl":"10.1016/j.phro.2025.100879","url":null,"abstract":"<div><h3>Background and purpose</h3><div>The role of dosimetry audits is well established in the development and verification of radiotherapy safety. Differences in planning and beam modelling make inter-centre comparisons challenging, which can be addressed through distribution of centrally created plans. This study developed a centralised planning approach applicable to multiple audit methodologies, using an example of remote patient specific quality assurance assessment, increasing the interpretability of results and facilitating automation and scalability.</div></div><div><h3>Material and methods</h3><div>Starting with an established plan which met all clinical goals, a commercial dose mimicking algorithm was used to replicate this plan to be suitable for multiple treatment machines. Beam and machine limitation data were collected from participating centres to develop universally acceptable beam models. The influence of variation in beam modelling parameters among centres was assessed by creating additional models using the 2.5th, 25th, 75th and 97.5th percentiles of previously reported data. Multi-leaf collimator angle and leaf position, gantry angle and output deviations were then introduced into copies of these plans.</div></div><div><h3>Results</h3><div>Introduced delivery errors caused consistent change in dose metrics across machine models (excluding outliers) with a median (range) standard deviation of 1.0 % (from 0.1 % to 1.7 %) demonstrating similar robustness. Beam model variation did not change whether simulated delivery errors were clinically impactful or not for 95 % of tested plans.</div></div><div><h3>Conclusion</h3><div>This study lays the foundation for future standardised methodology for dosimetry audits by providing a centralised planning approach that allows a more consistent assessment of centres.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"36 ","pages":"Article 100879"},"PeriodicalIF":3.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145681029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Physics and Imaging in Radiation Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1